<code id='A5CF921995'></code><style id='A5CF921995'></style>
    • <acronym id='A5CF921995'></acronym>
      <center id='A5CF921995'><center id='A5CF921995'><tfoot id='A5CF921995'></tfoot></center><abbr id='A5CF921995'><dir id='A5CF921995'><tfoot id='A5CF921995'></tfoot><noframes id='A5CF921995'>

    • <optgroup id='A5CF921995'><strike id='A5CF921995'><sup id='A5CF921995'></sup></strike><code id='A5CF921995'></code></optgroup>
        1. <b id='A5CF921995'><label id='A5CF921995'><select id='A5CF921995'><dt id='A5CF921995'><span id='A5CF921995'></span></dt></select></label></b><u id='A5CF921995'></u>
          <i id='A5CF921995'><strike id='A5CF921995'><tt id='A5CF921995'><pre id='A5CF921995'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:461

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

          advertisement

          Sponsor introduction

          • John Arena, SVP, enterprise strategy & solutions, Cencora

          Featured speakers

          • Tara Bannow, hospitals and insurance reporter, STAT
          • Damian Garde, national biotech reporter, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Allison DeAngelis, biotech startups and venture capital reporter, STAT (moderator)

          Sponsored By

          Cencora

          knowledge

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          Readout Newsletter: Bristol, Sangamo, Gilead, and more
          Readout Newsletter: Bristol, Sangamo, Gilead, and more

          EricRisberg/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsl

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

          AdobeAcadiaPharmaceuticalssaidMondaythatitsapprovedmedicinecalledNuplazidfailedtoimprovethesocialand